ZOD signed a strategic cooperation framework agreement with Ningbo Graphene Innovation Center

ZOD signed a strategic cooperation framework agreement with Ningbo Graphene Innovation Center, aiming to collaboratively promote graphene technology innovation and industrialization. Both parties will integrate resources, leverage their advantages in the fields of graphene materials and organic chemicals, achieve mutual benefits, and promote the transformation and application of technological research and development results

ZOD is currently up over 5%, with an amplitude of 20.01% and a transaction amount exceeding 400 million yuan

ZOD performs "Heaven and Earth Board"

ZOD hit the daily limit down during trading, performing a "Heaven and Earth Board," with a transaction volume of 405 million yuan

ZOD: ZHEJIANGEXPRESS plans to conduct a stock swap to absorb and merge with ZOD, resuming trading on September 3rd

ZOD announced a stock swap absorption merger with ZHEJIANGEXPRESS, with a swap ratio of 1:1.0800. After the merger, ZHEJIANGEXPRESS will take over ZOD's existing business, expand into the chemical industry, and form deep synergies in areas such as new energy transportation infrastructure construction. This restructuring aims to optimize the company's governance structure, improve resource allocation efficiency, and enhance the core competitiveness of the enterprise. The company's A-share stocks and convertible bonds will resume trading on September 3, 2025

ZOD: Major asset restructuring plan disclosed, the company will resume trading on September 3, 2025

ZOD announced that the company is planning a major asset restructuring and intends to absorb and merge with the company by issuing A-shares to all shareholders in exchange for shares. Due to the transaction being in the planning stage, there is significant uncertainty. The company will be suspended from trading on August 20, 2025, and is expected to resume trading on September 3, 2025. The board of directors has reviewed the relevant proposals, but the audit, valuation, and other work have not yet been completed, and the shareholders' meeting will not be held for the time being. The transaction plan needs to be reviewed and approved by the board of directors and the shareholders' meeting, and investors should pay attention to the related risks